AI-guided patient stratification improves outcomes and efficiency in the AMARANTH Alzheimer’s Disease clinical trial

Journal:

Nature Communications

Published:

2025-07-17

DOI:

10.1038/s41467-025-61355-3

Affiliations:

5

Authors:

7

Go to article

Institutions	Authors	Share
University of Cambridge, United Kingdom (UK)	2.000000	0.29
AstraZeneca Cambridge, United Kingdom (UK)	2.000000	0.29
AstraZeneca Gaithersburg, MD, United States of America (USA)	1.000000	0.14
AstraZeneca United States, United States of America (USA)	1.000000	0.14
University of Birmingham, United Kingdom (UK)	1.000000	0.14

Interested in Neurosciences?